Add BrightSurf on Google Email

NRG Oncology/Alliance trial finds immunotherapy did not improve survival when added to chemoradiotherapy for small cell lung cancer

The NRG-LU005 trial found that immunotherapy atezolizumab did not improve survival for patients with limited-stage small cell lung cancer when added to chemoradiation. Twice-daily radiation therapy, however, was associated with improved survival in this population.

SourceAlliance for Clinical Trials in Oncology·JournalJournal of Clinical Oncology·TypeRandomized controlled/clinical trial·DateMar 12, 2026

Doubling of new prescriptions for ADHD medications among adults since start of COVID-19 pandemic

New prescriptions for stimulants among adults with ADHD more than doubled since the COVID-19 pandemic, with the largest increases among younger adults. The trend is driven by improved recognition and treatment of ADHD in adulthood, as well as increased access to care and virtual health services.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeObservational study·DateMar 9, 2026

Maternal acetaminophen use and child neurodevelopment

A study in Taiwan found a positive association between maternal prenatal acetaminophen use and increased risk of attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASDs) in offspring. However, associations were not observed in sibling-matched analyses, suggesting unaddressed sources of bias.

SourceJAMA Network·JournalJAMA Pediatrics·DateMar 9, 2026

People with COPD commonly misuse medications

New studies reveal that medication nonadherence in people with chronic obstructive pulmonary disease (COPD) is often caused by affordability and limited understanding of medications. This can lead to quicker lung function decline, more frequent exacerbations, and a higher symptom burden.

SourceCOPD Foundation·JournalChronic Obstructive Pulmonary Diseases Journal of the COPD Foundation·DateMar 4, 2026

Sugar comforts newborn babies during painful procedures

A new Cochrane review found that sucrose can effectively reduce pain in newborn babies during painful procedures like venepuncture. The study examined 29 clinical trials involving over 2,700 babies and showed that a small amount of sucrose given before the procedure significantly reduces pain when combined with non-nutritive sucking.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateMar 3, 2026

Low-dose lithium for mild cognitive impairment

Researchers investigated low-dose lithium as a potential treatment for mild cognitive impairment in a pilot clinical trial. The study found that none of the primary outcomes met the significance threshold, but effect size estimates suggest potential benefits for future trials.

SourceJAMA Network·JournalJAMA Neurology·DateMar 2, 2026

Aspirin not a quick fix for preventing bowel cancer

Daily aspirin use offers no quick or reliable way to prevent bowel cancer in the general population, increasing risk of serious bleeding. However, it may have potential long-term benefits for people at high genetic risk of colorectal cancer.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateFeb 25, 2026

GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients

A new study by Harvard T.H. Chan School of Public Health and the Department of Veterans Affairs Boston Healthcare System found that using GLP-1 receptor agonists in combination with adhering to healthy lifestyle habits significantly reduces cardiovascular risk among individuals with type 2 diabetes. The study showed that these two stra...

SourceHarvard T.H. Chan School of Public Health·JournalThe Lancet Diabetes & Endocrinology·TypeObservational study·DateFeb 25, 2026

Flipping and reversing mini-proteins could improve disease treatment

A team of researchers from Penn State and The University of Minnesota Medical School found that chemically changing the structure of a naturally occurring peptide can make it more stable and effective against antibiotic-resistant bacteria. The new shape imparted by the modified molecule allows it to physically degrade bacterial cell me...

SourcePenn State·JournalNature Communications·TypeExperimental study·DateFeb 13, 2026

New-onset nonarteritic anterior ischemic optic neuropathy and initiators of semaglutide in US veterans with type 2 diabetes

A nationwide cohort study found that semaglutide initiators had a significantly higher risk of developing nonarteritic anterior ischemic optic neuropathy compared to sodium-glucose cotransporter-2 inhibitor initiators. The absolute risk was low, but clinicians and patients should be aware of this rare but evident increased risk.

SourceJAMA Network·JournalJAMA Ophthalmology·DateFeb 12, 2026

Cancer incidence and mortality with aspirin in older adults

A recent study found that low-dose aspirin use was not associated with incident cancer incidence in older adults, contrary to previous findings. However, the study revealed a significant elevation in cancer mortality risk during the randomized clinical trial period, which did not persist after the trial ended.

SourceJAMA Network·JournalJAMA Oncology·DateJan 29, 2026

Long term use of anti-acid drugs may not increase stomach cancer risk

Researchers found no association between long term use of proton pump inhibitors and increased risk of stomach cancer. The study, which analyzed data from five Nordic countries over 26 years, suggests that patients needing long term proton pump inhibitor therapy may not need to worry about a higher risk of stomach cancer.

SourceBMJ Group·JournalThe BMJ·TypeObservational study·DateJan 21, 2026

Alliance trial reveals gene variant may affect prostate cancer drug efficacy

A major U.S. clinical trial has uncovered a genetic factor that may inform how to optimize the dosing of abiraterone, a widely used hormone treatment for advanced prostate cancer. Researchers found that men who carry a specific version of the gene SULT2A1 clear abiraterone from their bodies more slowly, which could affect how well it w...

SourceAlliance for Clinical Trials in Oncology·JournalClinical and Translational Science·TypeExperimental study·DateJan 14, 2026

Valacyclovir treatment of early symptomatic Alzheimer disease

Researchers found that valacyclovir, an antiviral medication, was ineffective in treating early symptomatic Alzheimer's disease and may even worsen cognitive function. The study suggests that individuals with early symptomatic Alzheimer's disease and herpes simplex virus seropositivity should not be treated with valacyclovir.

SourceJAMA Network·JournalJAMA·DateDec 17, 2025

Combination pills for high blood pressure may simplify treatment, improve long-term health

A new American Heart Association scientific statement suggests that combination pills combining two or more medications may help adults with high blood pressure achieve optimal blood pressure goals more quickly, reduce their risk of heart attack and stroke, and improve long-term health. Currently, most people need two or more medicatio...

SourceAmerican Heart Association·JournalHypertension·DateDec 15, 2025

Reproduced human neural circuits show the crucial role of the thalamus in shaping the cortical circuit

Scientists have successfully replicated human neural circuits using assembloids, a type of miniature organoid derived from induced pluripotent stem cells. The study shows that the thalamus plays a crucial role in shaping cell-type specific neural circuits in the human cerebral cortex, promoting cortical growth and maturation.

SourceNagoya University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateDec 12, 2025

Population-level trends in ADHD medication prescribing

A repeated cross-sectional study found a significant increase in stimulant prescribing for ADHD, with the largest acceleration observed among female adolescents and young adults aged 18 to 64. The study's findings are consistent with prior research but provide new insights into population-level trends.

SourceJAMA Network·JournalJAMA Network Open·DateDec 11, 2025